Abstract
Glucuronidation has been recognized as an important clearance mechanism in humans. Therefore, knowledge about the contribution of glucuronidation to clearance of drug candidates is of great value in early drug development. In this article, we discuss the recent progress made to predict in vivo glucuronidation parameters (e.g., hepatic clearance, and intestinal availability) using in vitro data, which are readily obtained using microsomes and hepatocytes, so called “in vitro- in vivo extrapolation” (IVIVE). Of note the intrinsic clearances obtained from microsomal incubations in the presence of bovine serum albumin (BSA) provide accurate predictions of the in vivo clearances in addition to those from hepatocytes. Further, we describe the lack of correlation between cellular and microsomal production of glucuronide and provide possible reasons. Due to the high prediction accuracy, those who study in vitro glucuronidation are encouraged to map their data to in vivo using IVIVE strategy for more informative data interpretation.
Keywords: Drug metabolism, glucuronidation, UGTs, in vitro-in vitro extrapolation, in vitro-in vitro correlation, quantitative prediction.
Current Topics in Medicinal Chemistry
Title:Quantitative Prediction of Glucuronidation in Humans Using the In Vitro- In Vivo Extrapolation Approach
Volume: 13 Issue: 11
Author(s): Baojian Wu, Dong Dong, Ming Hu and Shuxing Zhang
Affiliation:
Keywords: Drug metabolism, glucuronidation, UGTs, in vitro-in vitro extrapolation, in vitro-in vitro correlation, quantitative prediction.
Abstract: Glucuronidation has been recognized as an important clearance mechanism in humans. Therefore, knowledge about the contribution of glucuronidation to clearance of drug candidates is of great value in early drug development. In this article, we discuss the recent progress made to predict in vivo glucuronidation parameters (e.g., hepatic clearance, and intestinal availability) using in vitro data, which are readily obtained using microsomes and hepatocytes, so called “in vitro- in vivo extrapolation” (IVIVE). Of note the intrinsic clearances obtained from microsomal incubations in the presence of bovine serum albumin (BSA) provide accurate predictions of the in vivo clearances in addition to those from hepatocytes. Further, we describe the lack of correlation between cellular and microsomal production of glucuronide and provide possible reasons. Due to the high prediction accuracy, those who study in vitro glucuronidation are encouraged to map their data to in vivo using IVIVE strategy for more informative data interpretation.
Export Options
About this article
Cite this article as:
Wu Baojian, Dong Dong, Hu Ming and Zhang Shuxing, Quantitative Prediction of Glucuronidation in Humans Using the In Vitro- In Vivo Extrapolation Approach, Current Topics in Medicinal Chemistry 2013; 13 (11) . https://dx.doi.org/10.2174/15680266113139990038
DOI https://dx.doi.org/10.2174/15680266113139990038 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis, Computational Study, and Evaluation of In Vitro Antimicrobial, Antibiofilm, and Anticancer Activities of New Sulfanyl Aminonaphthoquinone Derivatives
Letters in Drug Design & Discovery A Review of Shearwave Dispersion Ultrasound Vibrometry (SDUV) and its Applications
Current Medical Imaging A Refined Framework for Precision and Translational Proteomics in Clinical Research
Current Proteomics Disordered Interactome of Human Papillomavirus
Current Pharmaceutical Design Tricyclic Antidepressants-loaded Biodegradable PLGA Nanoparticles: In Vitro Characterization and In Vivo Analgesic and Anti-Allodynic Effect
Current Nanoscience Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction
Current Medicinal Chemistry ADR in Journals: Are They Translated into Regulatory Frameworks?
Current Drug Safety The Synthesis, Structural Modification and Mode of Anticancer Action of Evodiamine: A Review
Recent Patents on Anti-Cancer Drug Discovery Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia
Anti-Cancer Agents in Medicinal Chemistry Advances and Challenges in Kidney Organoids
Current Stem Cell Research & Therapy Graphenoxide Cross-Linker Based Potentiometric Biosensor Design for Sarcosine Determination
Protein & Peptide Letters Development of Immunopharmacotherapy Against Drugs of Abuse
Current Drug Discovery Technologies Changing Faces of Transcriptional Regulation Reflected by Zic3
Current Genomics Oxidative RNA Damage and Neurodegeneration
Current Medicinal Chemistry Recent Advances in Substrate Identification of Protein Kinases in Plants and Their Role in Stress Management
Current Genomics New Synthesis of Isoindolo[2,1–b]isoquinolines. Preparation and Aqueous Bioavailability of its Silica Nanoparticles Hybrid System
Current Organic Chemistry Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Current Pharmaceutical Design Toxicological Effects of Dietary Biogenic Amines
Current Nutrition & Food Science Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease
Recent Patents on CNS Drug Discovery (Discontinued) Effect of Nanotechnology Approaches on Anti-retroviral Molecule: Efavirenz
Current Organic Chemistry